-
Can Generative AI Automate Health Economic Model Verification?
Sep 9, 2025, 16:22 PM -
Epidemiology and Outcomes in a Linked Cohort of Cancer Pathology and Electronic Medical Records From the PHARMO Data Network
Sep 9, 2025, 16:22 PM -
Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
The Relationship Between Surrogate Endpoints and Overall Survival in Myelofibrosis Clinical Trials: Results From a Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Human Alignment on Evaluating LLMs for Literature Review Extraction
Sep 9, 2025, 16:22 PM -
Reducing the Transmission and Annual Burden of Influenza in the UK With Baloxavir Marboxil: A Cost-Effectiveness Analysis Using Evidence From the CENTERSTONE Trial
Sep 9, 2025, 16:22 PM -
Systematic Literature Review of Artificial Intelligence-Based Models Predicting COPD Exacerbations
Sep 9, 2025, 16:22 PM -
How Can the Threshold Method Guide the Choice of Treatments? Illustration in French Patients With Hemophilia A or B
Sep 9, 2025, 16:22 PM -
Evaluating the Costs of Perioperative Iron-Deficiency Anemia Management in China: A Comparison of Ferric Derisomaltose, Ferric Carboxymaltose, and Usual Care
Sep 9, 2025, 16:22 PM -
Knowledge and Attitudes Regarding the HPV Vaccine Among Secondary School Students
Sep 9, 2025, 16:22 PM -
CAR-NK Cell Therapy for Ovarian Cancer Treatment in the First Relapse: Assessing Conditions Needed for Cost-Effectiveness in the Netherlands Using Early Health-Economic Modeling
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Control-IQ Hybrid Closed-Loop System in Adults With Type 1 Diabetes in Sweden
Sep 9, 2025, 16:22 PM -
The Preferences for Advanced Therapy Medicinal Products: A Multicriteria Decision Analysis Framework
Sep 9, 2025, 16:22 PM -
Real-World Cost-Utility of Faricimab vs. Current and Future Anti-VEGF Therapies in Patients With Neovascular Age-Related Macular Degeneration in Italy
Sep 9, 2025, 16:22 PM -
Real-World Outcomes and Economic Impact of Ribociclib in HR+/HER2- Advanced Breast Cancer: Evidence From the Portuguese REASSURE Cohort
Sep 9, 2025, 16:22 PM -
Development of Two Versions of a Patient-Reported Outcome Measure to Evaluate Participant Experience and Satisfaction During the Intervention and Analytical Treatment Interruption Periods of Cure-Related and Other HIV Trials
Sep 9, 2025, 16:22 PM -
Economic Burden of Progressive Pulmonary Fibrosis (PPF) in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Analysis of the Epidemiological Disease Burden of Endometriosis in Hungary Based on Data From the Global Burden of Disease Study
Sep 9, 2025, 16:22 PM -
Overcoming Patient Access Barriers in Complex Conditions: Lessons From Schizophrenia for Broader Healthcare Applications
Sep 9, 2025, 16:22 PM -
Managed Reimbursement of Continuous Glucose Monitoring Sensors in Ireland: Year One Review
Sep 9, 2025, 16:22 PM
